ARTICLE | Company News
Molzym GmbH & Co. KG, NorDiag deal
February 22, 2010 8:00 AM UTC
The companies will partner to develop and market a PCR-based diagnostic for sepsis. The test detects DNA from 345 strains of bacterial, yeast and fungal pathogens isolated from human samples. NorDiag ...